Clinical Trial Update: Efficacy and Safety of Alisporivir Alone or Combined With RBV or PEG in Chronic Hepatitis C Genotype 2 and 3 Treatment-naïve Participants [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating alisporivir alone or with ribavirin or pegylated interferon in treatment-naïve chronic hepatitis C patients with genotypes 2 and 3; stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Alisporivir (alisporivir)
• Pegylated interferon (pegylated interferon alfa)
• Ribavirin (ribavirin)

Snippet

Sponsor: Debiopharm International SA | Conditions: Hepatitis C, Chronic Pain | Phase 2 | Status: COMPLETED | Results posted: 2016-08-30